Current status of retinoids in chemoprevention of oral squamous cell carcinoma: an overview

Ah-See, 1994, An allelotype of squamous carcinoma of the head and neck using microsatellite markers, Cancer Res., 54, 1617 Banoczy, 1982, Oral leukoplakia, 15 Benner, 1994, Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up, J. Natl. Cancer Inst., 86, 140, 10.1093/jnci/86.2.140 Bolla, 1994, Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study, Eur. J. Cancer, 30A, 767, 10.1016/0959-8049(94)90290-9 Bollag, 1979, Retinoids and cancer. Cancer Chemother, Pharmacol., 3, 207 Boone, 1992, Natural history of intraepithelial neoplasia in humans with implications for cancer chemopreventive strategy, Cancer Res., 52, 1651 Brennan, 1995, Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck, N. Engl. J. Med., 332, 429, 10.1056/NEJM199502163320704 Chiesa, 1992, Prevention of local relapse and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results, Oral Oncol. Eur. J. Cancer, 28B, 97, 10.1016/0964-1955(92)90035-Y Chu, 1988, CO2 laser treatment of oral leukoplakia, Laryngoscope, 98, 125, 10.1288/00005537-198802000-00001 Costa, 1989, Tolerability of the synthetic retinoid Fenretinide (HPR), Eur. J. Cancer, 25, 805, 10.1016/0277-5379(89)90124-7 Decensi, 1994, Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface, J. Natl. Cancer Inst., 86, 105, 10.1093/jnci/86.2.105 Formelli, 1993, Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations, J. Clin. Oncol., 10, 2036, 10.1200/JCO.1993.11.10.2036 Gallo, 1995, p53 expression: a potential biomarker for risk of multiple primary malignancies in the upper aerodigestive tract, Oral Oncol. Eur. J. Cancer, 31B, 53, 10.1016/0964-1955(94)00031-X Garewal, 1990, Response of oral leukoplakia to beta-carotene, J. Clin. Oncol., 8, 1715, 10.1200/JCO.1990.8.10.1715 Gridley, 1990, Diet and oral pharyngeal cancer among blacks, Nutr. Cancer, 14, 219, 10.1080/01635589009514096 Halpern, 1994, Effects of topical tretinoin on dysplastic nevi, J. Clin. Oncol., 12, 1028, 10.1200/JCO.1994.12.5.1028 Hansen, 1985, Proliferative verrucous leukoplakia, Oral Surg., 60, 285, 10.1016/0030-4220(85)90313-5 Hong, 1986, 13-cis retinoic acid in the treatment of oral leukoplakia, New Engl. J. Med., 315, 1501, 10.1056/NEJM198612113152401 Hong, 1990, Prevention of second primary tumors with isotretinion in squamous-cell carcinoma of the head and neck, N. Engl. J. Med., 323, 795, 10.1056/NEJM199009203231205 Hong, 1995, Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic, Clin. Cancer Res., 1, 677 Hu, 1991, Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines, Cancer Res., 51, 3972 Kaugars, 1995, The use of 13-cis-retinoic acid in the treatment of oral leukoplakia: short-term observations, Oral Surg. Oral Med. Oral Pathol., 79, 264, 10.1016/S1079-2104(05)80211-2 Koch, 1978, Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid, J. Maxillofac. Surg., 6, 59, 10.1016/S0301-0503(78)80069-1 Lippman, 1992, 13-cis retinoic acid and interferon-alpha 2a: effective combination therapy for advanced squamous cell carcinoma of the skin, J. Natl. Cancer Inst., 84, 235, 10.1093/jnci/84.4.235 Lippman, 1992, 13-cis retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix, J. Natl. Cancer Inst., 84, 241, 10.1093/jnci/84.4.241 Lippman, 1993, Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis, New Engl. J. Med., 328, 15, 10.1056/NEJM199301073280103 Lippman, 1995, p53 and retinoid chemoprevention of oral carcinogenesis, Cancer Res., 55, 16 Loeb, 1994, Microsatellite instability: marker of a mutator phenotype in cancer, Cancer Res., 54, 5059 Lotan, 1995, Suppression of retinoic acid receptor beta in premalignant oral lesions and its upregulation by isotretinoin, N. Engl. J. Med., 332, 1405, 10.1056/NEJM199505253322103 Lumerman, 1995, Oral epithelial dysplasia and the development of invasive squamous cell carcinoma, Oral Surg. Oral Med. Oral Pathol., 79, 321, 10.1016/S1079-2104(05)80226-4 Mariotti, 1994, N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells, J. Natl. Cancer Inst., 86, 1245, 10.1093/jnci/86.16.1245 McLaughlin, 1988, Dietary factors in oral and pharyngeal cancer, J. Natl. Cancer Inst., 80, 1237, 10.1093/jnci/80.15.1237 Meyskens, 1994, Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically-applied all-trans retinoic acid: a randomized trial, J. Natl. Cancer Inst., 86, 539, 10.1093/jnci/86.7.539 Million, 1994, Natural history of squamous cell carcinoma, 31 Nakanishi, 1995, p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract, Cancer, 75, 1658, 10.1002/1097-0142(19950401)75:7<1657::AID-CNCR2820750716>3.0.CO;2-G Newton, 1980, Structure activity relationships of retinoids in hamster tracheal organ culture, Cancer Res., 40, 3413 Pindborg, 1968, Studies with oral leukoplakia: a preliminary report on the period prevalence of malignant transformation in leukoplakia based on a followup study of 248 patients, J. Am. Dent. Assoc., 78, 767, 10.14219/jada.archive.1968.0127 Ponzoni, 1995, Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation, Cancer Res., 55, 853 Regezi, 1995, p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas, J. Oral Pathol. Med., 24, 18, 10.1111/j.1600-0714.1995.tb01124.x Shah, 1983, Effect of retinoids on oral leukoplakia, Am. J. Surg., 146, 466, 10.1016/0002-9610(83)90232-5 Sheikh, 1995, N-(4-hydroxyphenyl)-retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma, Carcinogenesis, 16, 2477, 10.1093/carcin/16.10.2477 Sies, 1992, Antioxidant functions of vitamins: vitamins E and C, beta carotene and other carotenoids, Ann. NY. Acad. Sci., 669, 7, 10.1111/j.1749-6632.1992.tb17085.x Silverman, 1984, Oral leukoplakia and malignant transformation. A follow-up study of 257 patients, Cancer, 53, 563, 10.1002/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F Silverman, 1984, Toluidine blue staining of oral precancerous and malignant lesions, Oral Surg. Oral Med. Oral Pathol., 57, 349, 10.1016/0030-4220(84)90154-3 Slaughter, 1953, ‘Field cancerization’ in oral stratified squamous epithelium: clinical implications of multicentric origin, Cancer, 6, 963, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q Smith, 1992, Retinoids in cancer therapy, J. Clin. Oncol., 10, 839, 10.1200/JCO.1992.10.5.839 Stam, 1990, Vitamins and lung cancer, Lung, 168, 1075, 10.1007/BF02718246 Stich, 1987, Micronucleated exfoliated cells as indicators for genotoxic damage and as markers in chemoprevention trials, J. Nutr. Growth Cancer, 4, 9 Stich, 1988, Response of oral leukoplakias to the administration of vitamin A, Cancer Lett., 40, 93, 10.1016/0304-3835(88)90266-2 Stich, 1988, Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A, Eur. J. Cancer, 42, 195 Swisshelm, 1994, Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its upregulation in senescing normal mammary epithelial cells, Cell Growth Differ., 5, 133 Tradati, 1994, Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR), Cancer Lett., 76, 109, 10.1016/0304-3835(94)90385-9 vander Riet, 1994, Frequent loss of chromosome 9p21-22 early in head and neck cancer progression, Cancer Res., 54, 1156 Waldron, 1975, Leukoplakia revisited: a clinicopathologic study of 3256 oral leukoplakias, Cancer, 36, 1386, 10.1002/1097-0142(197510)36:4<1386::AID-CNCR2820360430>3.0.CO;2-7 Xu, 1994, Differential expression of nuclear retinoic acid receptors in normal, premalignant and malignant head and neck tissues, Cancer Res., 54, 3580 Zheng, 1993, Serum micronutrients and the subsequent risk of oral and pharyngeal cancer, Cancer Res., 53, 795